1. Home
  2. COEP vs ZCMD Comparison

COEP vs ZCMD Comparison

Compare COEP & ZCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • ZCMD
  • Stock Information
  • Founded
  • COEP 2017
  • ZCMD 2012
  • Country
  • COEP United States
  • ZCMD China
  • Employees
  • COEP N/A
  • ZCMD N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • ZCMD Other Consumer Services
  • Sector
  • COEP Health Care
  • ZCMD Real Estate
  • Exchange
  • COEP Nasdaq
  • ZCMD Nasdaq
  • Market Cap
  • COEP 27.4M
  • ZCMD 29.0M
  • IPO Year
  • COEP N/A
  • ZCMD 2020
  • Fundamental
  • Price
  • COEP $9.84
  • ZCMD $1.14
  • Analyst Decision
  • COEP
  • ZCMD
  • Analyst Count
  • COEP 0
  • ZCMD 0
  • Target Price
  • COEP N/A
  • ZCMD N/A
  • AVG Volume (30 Days)
  • COEP 37.4K
  • ZCMD 506.1K
  • Earning Date
  • COEP 08-15-2025
  • ZCMD 01-01-0001
  • Dividend Yield
  • COEP N/A
  • ZCMD N/A
  • EPS Growth
  • COEP N/A
  • ZCMD N/A
  • EPS
  • COEP N/A
  • ZCMD N/A
  • Revenue
  • COEP $62,874.00
  • ZCMD $15,864,773.00
  • Revenue This Year
  • COEP N/A
  • ZCMD N/A
  • Revenue Next Year
  • COEP N/A
  • ZCMD N/A
  • P/E Ratio
  • COEP N/A
  • ZCMD N/A
  • Revenue Growth
  • COEP N/A
  • ZCMD N/A
  • 52 Week Low
  • COEP $2.31
  • ZCMD $0.95
  • 52 Week High
  • COEP $13.70
  • ZCMD $2.97
  • Technical
  • Relative Strength Index (RSI)
  • COEP 62.24
  • ZCMD 48.00
  • Support Level
  • COEP $7.25
  • ZCMD $1.13
  • Resistance Level
  • COEP $9.90
  • ZCMD $1.24
  • Average True Range (ATR)
  • COEP 0.63
  • ZCMD 0.11
  • MACD
  • COEP 0.26
  • ZCMD -0.01
  • Stochastic Oscillator
  • COEP 85.62
  • ZCMD 21.84

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About ZCMD Zhongchao Inc.

ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.

Share on Social Networks: